ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy.

Veenstra, V L; Damhofer, H; Waasdorp, C; van Rijssen, L B; van de Vijver, M J; Dijk, F; Wilmink, H W; Besselink, M G; Busch, O R; Chang, D K; Bailey, P J; Biankin, A V; Kocher, H M; Medema, J P; Li, J S; Jiang, R; Pierce, D W; van Laarhoven, H W M; Bijlsma, M F

Veenstra, V L; Damhofer, H; Waasdorp, C; van Rijssen, L B; van de Vijver, M J; Dijk, F; Wilmink, H W; Besselink, M G; Busch, O R; Chang, D K; Bailey, P J; Biankin, A V; Kocher, H M; Medema, J P; Li, J S; Jiang, R; Pierce, D W; van Laarhoven, H W M; Bijlsma, M F.

Afiliação

Veenstra VL; Amsterdam UMC, University of Amsterdam, LEXOR, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam, Netherlands.
Damhofer H; Oncode Institute, Meibergdreef 9, 1105AZ, Amsterdam, Netherlands.
Waasdorp C; Amsterdam UMC, University of Amsterdam, LEXOR, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam, Netherlands.
van Rijssen LB; Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark.
van de Vijver MJ; Amsterdam UMC, University of Amsterdam, LEXOR, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam, Netherlands.
Dijk F; Oncode Institute, Meibergdreef 9, 1105AZ, Amsterdam, Netherlands.
Wilmink HW; Amsterdam UMC, University of Amsterdam, Department of Surgery, Cancer Center Amsterdam, Amsterdam, Netherlands.
Besselink MG; Amsterdam UMC, University of Amsterdam, Department of Pathology, Cancer Center Amsterdam, Amsterdam, Netherlands.
Busch OR; Amsterdam UMC, University of Amsterdam, Department of Pathology, Cancer Center Amsterdam, Amsterdam, Netherlands.
Chang DK; Amsterdam UMC, University of Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, Netherlands.
Bailey PJ; Amsterdam UMC, University of Amsterdam, Department of Surgery, Cancer Center Amsterdam, Amsterdam, Netherlands.
Biankin AV; Amsterdam UMC, University of Amsterdam, Department of Surgery, Cancer Center Amsterdam, Amsterdam, Netherlands.
Kocher HM; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
Medema JP; West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, UK.
Li JS; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
Jiang R; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
Pierce DW; West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, UK.
van Laarhoven HWM; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.
Bijlsma MF; Amsterdam UMC, University of Amsterdam, LEXOR, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam, Netherlands.

Oncogenesis ; 7(11): 87, 2018 Nov 16.

Article em En | MEDLINE | ID: mdl-30442938

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncogenesis Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google